Skip to Primary Navigation

Skip to main content

Medical technologies in defense and aerospace

Experiment with Brain-Computer Interface (BCI) in neuroscience laboratory
Photo: EThamPhoto/Getty Images

Amélie Chollet | CMS, Dr. Roland Wiring, Agnieszka Starzyńska | CMS+1

4 min read
 Click to share on Facebook (Opens in new window/tab) Click to share on Twitter (Opens in new window/tab) Click to share on LinkedIn (Opens in new window/tab) Click to share on WhatsApp (Opens in new window/tab)

Key themes and emerging questions in regulation.

In brief

  • The EU and the UK are increasingly viewing medical technologies and biotechnology as integral components of their security and defense strategies, both military and civilian, bringing life sciences regulation into direct contact with defense and aerospace frameworks.
  • For most products, the standard EU and UK life sciences framework
, , , , , , , , , , , ,

Get full access, free for a month

Start your 28-day free trial to continue reading and access
all content on GRIP – no payment details required.

Start free trial Sign in

What’s included:

  • Every new article, plus our 5,000+ archive
  • Daily regulatory insight and guidance
  • Exclusive interviews and in-depth analysis
  • Coverage of industry-leading events and conferences
  • All podcasts and videos, featuring industry experts
  • The full set of Rules Navigator tools
  • An ad-free experience